Literature DB >> 18456645

Inappropriate implantable cardioverter defibrillator shocks in fractured Sprint Fidelis leads associated with 'appropriate' interrogation.

David Farwell1, Calum Redpath, David Birnie, Michael Gollob, Robert Lemery, Emoke Posan, Martin Green.   

Abstract

We present two patients with fractures within the pace-sense circuit of their Medtronic Sprint Fidelis leads who received inappropriate shocks from their Medtronic defibrillators during device interrogation. This was not simply a coincidence, but due to electromagnetic interference induced within the Sprint Fidelis lead by the device programmer during two-way communication with the defibrillator. Our subsequent investigations have uncovered at least two other similar incidents in Canada. We have also discovered that the Medtronic 'Auto-resume' feature may leave future patients uniquely vulnerable to such inappropriate shocks in the future.

Entities:  

Mesh:

Year:  2008        PMID: 18456645     DOI: 10.1093/europace/eun113

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  2 in total

1.  Formation of a national network for rapid response to device and lead advisories: The Canadian Heart Rhythm Society Device Advisory Committee.

Authors:  Andrew D Krahn; Christopher S Simpson; Ratika Parkash; Raymond Yee; Jean Champagne; Jeffrey S Healey; Doug Cameron; Bernard Thibault; Iqwal Mangat; Stanley Tung; Laurence Sterns; David H Birnie; Derek V Exner; Soori Sivakumaran; Ted Davies; Benoit Coutu; Eugene Crystal; Kevin Wolfe; Atul Verma; Elizabeth A Stephenson; Shubhayan Sanatani; Robert Gow; Sean Connors; Felix Ayala Paredes; Mike Turabian; Teresa Kus; Vidal Essebag; Martin Gardner
Journal:  Can J Cardiol       Date:  2009-07       Impact factor: 5.223

2.  Generator and lead-related complications of implantable cardioverter defibrillators.

Authors:  Ahmad Yaminisharif; Nader Soofizadeh; Akbar Shafiee; Ali Kazemisaeid; Arash Jalali; Ali Vasheghani-Farahani
Journal:  Int Cardiovasc Res J       Date:  2014-04-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.